Literature DB >> 21835562

A survey study to characterize use of Spice products (synthetic cannabinoids).

Ryan Vandrey1, Kelly E Dunn, Jeannie A Fry, Elizabeth R Girling.   

Abstract

BACKGROUND: Synthetic cannabinoids are a rapidly emerging class of abused drugs. Synthetic cannabinoids are typically sold as "herbal blends" or "incense," commonly referred to as Spice products. No controlled human experiments have been conducted on the effects of Spice products or the synthetic cannabinoids they often contain.
METHODS: An internet-based survey study was conducted with adults reporting at least one lifetime use of a Spice product.
RESULTS: Respondents were primarily male, Caucasian and ≥ 12 years of education. Use of other psychoactive drugs was common, though 21% identified Spice products as their preferred drug. Spice products were most frequently obtained from retail vendors and smoked, though other forms of ingestion were endorsed. Mean age of first use was 26 and mean frequency of use in the past year was 67 days (range 0-365). Primary reasons for use were curiosity, positive drug effect, relaxation, and to get high without having a positive drug test. Acute subjective effects were similar to known effects of cannabis, and a subset of users met DSM criteria for abuse and dependence on Spice products.
CONCLUSIONS: Participants exhibited a diverse profile of use patterns as is typical for other drugs of abuse. There was evidence that users continued to seek and use these drugs after being banned by local authorities. This study should be interpreted with caution due to methodological limitations. Controlled laboratory research is needed to further examine the behavioral pharmacology of individual synthetic cannabinoids found in Spice products.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835562      PMCID: PMC3217086          DOI: 10.1016/j.drugalcdep.2011.07.011

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  18 in total

1.  The emergence and analysis of synthetic cannabinoids.

Authors:  Simon Hudson; John Ramsey
Journal:  Drug Test Anal       Date:  2011-02-21       Impact factor: 3.345

2.  Marijuana withdrawal among adults seeking treatment for marijuana dependence.

Authors:  A J Budney; P L Novy; J R Hughes
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

3.  New data from the Addiction Severity Index. Reliability and validity in three centers.

Authors:  A T McLellan; L Luborsky; J Cacciola; J Griffith; F Evans; H L Barr; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1985-07       Impact factor: 2.254

4.  "Spice" girls: synthetic cannabinoid intoxication.

Authors:  Aaron B Schneir; Jennifer Cullen; Binh T Ly
Journal:  J Emerg Med       Date:  2010-12-17       Impact factor: 1.484

5.  Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

Authors:  Sebastian Dresen; Nerea Ferreirós; Michael Pütz; Folker Westphal; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2010-10       Impact factor: 1.982

Review 6.  The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.

Authors:  José Antonio López-Moreno; Gustavo González-Cuevas; Guillermo Moreno; Miguel Navarro
Journal:  Addict Biol       Date:  2008-04-16       Impact factor: 4.280

7.  Structure-activity relationships of indole- and pyrrole-derived cannabinoids.

Authors:  J L Wiley; D R Compton; D Dai; J A Lainton; M Phillips; J W Huffman; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1998-06       Impact factor: 4.030

8.  Construct validity of the dependence syndrome as measured by DSM-IV for different psychoactive substances.

Authors:  A Feingold; B Rounsaville
Journal:  Addiction       Date:  1995-12       Impact factor: 6.526

9.  Spice: a never ending story?

Authors:  Rainer Lindigkeit; Anja Boehme; Ina Eiserloh; Maike Luebbecke; Marion Wiggermann; Ludger Ernst; Till Beuerle
Journal:  Forensic Sci Int       Date:  2009-07-08       Impact factor: 2.395

10.  Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".

Authors:  Ulrich S Zimmermann; Patricia R Winkelmann; Max Pilhatsch; Josef A Nees; Rainer Spanagel; Katja Schulz
Journal:  Dtsch Arztebl Int       Date:  2009-07-03       Impact factor: 5.594

View more
  70 in total

1.  Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Authors:  Lisa K Brents; Anna Gallus-Zawada; Anna Radominska-Pandya; Tamara Vasiljevik; Thomas E Prisinzano; William E Fantegrossi; Jeffery H Moran; Paul L Prather
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

2.  Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.

Authors:  S Tai; W S Hyatt; C Gu; L N Franks; T Vasiljevik; L K Brents; P L Prather; W E Fantegrossi
Journal:  Pharmacol Res       Date:  2015-09-08       Impact factor: 7.658

3.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

Review 4.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

5.  Ischemic stroke after use of the synthetic marijuana "spice".

Authors:  Melissa J Freeman; David Z Rose; Martin A Myers; Clifton L Gooch; Andrea C Bozeman; W Scott Burgin
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

6.  Risk management strategies of synthetic cannabis users.

Authors:  Stephanie Campos; Ellen Benoit; Eloise Dunlap
Journal:  Drugs Alcohol Today       Date:  2019-09-02

7.  Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Timothy W Lefever; Julie A Marusich; Richard C Kevin; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-03-16       Impact factor: 4.030

8.  In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.

Authors:  Thomas F Gamage; Daniel G Barrus; Richard C Kevin; David B Finlay; Timothy W Lefever; Purvi R Patel; Megan A Grabenauer; Michelle Glass; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  Pharmacol Biochem Behav       Date:  2020-04-02       Impact factor: 3.533

9.  Female Ex-Offender Perspectives on Drug Initiation, Relapse, and Desire to Remain Drug Free.

Authors:  Adeline M Nyamathi; Neha Srivastava; Benissa E Salem; Sarah Wall; Jordan Kwon; Maria Ekstrand; Elizabeth Hall; Susan F Turner; Mark Faucette
Journal:  J Forensic Nurs       Date:  2016 Apr-Jun       Impact factor: 1.175

10.  Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.

Authors:  Erin E Bonar; Lisham Ashrafioun; Mark A Ilgen
Journal:  Drug Alcohol Depend       Date:  2014-07-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.